Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.4M Buy
4,190,195
+1,343,002
+47% +$14.5M 0.03% 652
2026
Q1
$24.1M Buy
2,847,193
+152,959
+6% +$1.67M 0.01% 1032
2025
Q4
$30.4M Buy
2,694,234
+1,427,442
+113% +$17.7M 0.02% 985
2025
Q3
$19M Buy
1,266,792
+748,013
+144% +$10.9M 0.01% 1204
2025
Q2
$7.32M Buy
518,779
+484,217
+1,401% +$8.63M 0.01% 1737
2025
Q1
$831K Sell
34,562
-136,085
-80% -$4.8M ﹤0.01% 3203
2024
Q4
$6.37M Sell
170,647
-407,076
-70% -$19M ﹤0.01% 1790
2024
Q3
$28.9M Buy
577,723
+37,297
+7% +$1.45M 0.02% 783
2024
Q2
$18.8M Buy
540,426
+284,094
+111% +$11.2M 0.02% 929
2024
Q1
$14M Buy
256,332
+46,451
+22% +$2.3M 0.01% 1143
2023
Q4
$8.98M Buy
209,881
+198,837
+1,800% +$6.18M 0.01% 1448
2023
Q3
$287K Buy
+11,044
New +$230K ﹤0.01% 3629
2023
Q1
Sell
-26,058
Closed -$362K 4445
2022
Q4
$362K Buy
+26,058
New +$368K ﹤0.01% 4013

Other funds holding BHVN

David Shaw's BHVN Position: Q2 2026 in Review

David Shaw increased its Biohaven (BHVN) stake by 47% in Q2 2026, buying an estimated $14.5M and bringing the position to 4,190,195 shares worth $62.4M. The position accounts for 0.03% of the portfolio, ranked #652.

David Shaw first reported a position in BHVN in Q4 2022 and has held it in 13 quarters since. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • David Shaw held 4,190,195 shares of Biohaven worth $62.4M as of Q2 2026.
  • David Shaw bought 1,343,002 Biohaven shares in Q2 2026, an estimated $14.5M.
  • Biohaven made up 0.03% of David Shaw's portfolio in Q2 2026, its #652 holding.
  • David Shaw first reported a position in Biohaven in Q4 2022 and has held it in 13 quarters since.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.